Core Insights - MetLife, Inc. is a leading global provider of insurance, annuities, and employee benefit programs, operating in over 40 countries and serving approximately 90 million customers [1] - The company has shown a modest gain of 1.38% over the past 30 days, reflecting investor confidence despite a recent 2.18% decline in the last 10 days, which may present a buying opportunity [2] - MetLife's stock has a projected growth potential of 21.39%, indicating it is currently undervalued with a target price set at $95.67, suggesting strong upside potential [3] - The company boasts a high Piotroski Score of 8 out of 9, reflecting strong financial health and efficient operations, which enhances its investment appeal [4] - Overall, MetLife presents a compelling investment opportunity due to its solid financial foundation and promising growth prospects, making it attractive for investors seeking stability and growth [5]